0 items USD 0.00Search
Your search for "globaldata relapsed chronic lymphocytic leukemia cll global clinical trials review h1 2018" gave back 688391 results.
Iclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
It is a highly potent opioid analgesic indicated for treatment of severe pain The global Oxymorphone Hydrochloride market is projected to grow from...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
The global Poly Polymerase 2 market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Besponsa...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Inotuzumab ozogamicin is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Autologous Immune Cell Storage market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
Catalog:
GIR
February 2024
Price: USD 3,480.00
The global T Lymphocyte Activation Antigen CD80 market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
